<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02911493</url>
  </required_header>
  <id_info>
    <org_study_id>16-1330</org_study_id>
    <nct_id>NCT02911493</nct_id>
  </id_info>
  <brief_title>Reducing Sedentary Time in Patients With Heart Failure</brief_title>
  <acronym>Rest-HF</acronym>
  <official_title>Reducing Sedentary Time in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the change in sedentary time and number of steps/day for older patients with
      heart failure at risk for mobility disability who receive a program to decrease sedentary
      behavior versus a standard program to increase exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2016</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Subjects that are more active than Control.</measure>
    <time_frame>Monthly for 3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Sedentary Group-Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to reduce sedentary time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Activity Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Active Comparative group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to increase exercise time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Reducing Sedentary Behavior</intervention_name>
    <description>The experimental group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to reduce sedentary time.</description>
    <arm_group_label>Sedentary Group-Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Activity Group</intervention_name>
    <description>The Active Comparative group will wear an activPAL and have counseling sessions that use the Health Belief Model and Motivational Interviewing strategies to increase exercise time.</description>
    <arm_group_label>Physical Activity Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NYHA II-IV,

          -  Age ≥ 65,

          -  SPPB score of &gt; 4 and ≤ 10 of 12,

               -  and deemed (by 1° cardiologist) to be at maximal tolerated dose of heart failure
                  medication (ACE-inhibitor (ACE-I)/angiotensin receptor blocker and beta blocker
                  (BB) for patients with HF with reduced ejection fraction (HFrEF), and

               -  blood pressure controlled for HF with preserved ejection fraction (HFpEF)
                  according to the American Heart Failure Association HF guidelines.

        Exclusion Criteria:

          -  Patients requiring medication titration such as ACE-I or BB, (will return to their
             cardiologist and be eligible after 3 months of stable medication.)

          -  Oxygen dependent lung disease,

          -  Orthopedic or neurologic disease that severely limits mobility,

          -  Active cancer diagnosis except non-melanoma skin cancer,

          -  Geriatric Depression Scale (GDS) score of ≥ 9 ,

          -  Limited life-expectancy of &lt;6 months,

          -  Known dementia or disease that effects ability to learn/follow directions, or

          -  Failed MiniCog test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rebecca Boxer, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado University</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2016</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sedentary time</keyword>
  <keyword>number of steps/day</keyword>
  <keyword>mobility</keyword>
  <keyword>disability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

